Effects of BufferGel and PRO 2000/5 Gel in Men

计划入组 24 人 · 首次发布于 2001 年 8 月 31 日

Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases

计划入组 57 人 · 首次发布于 2016 年 9 月 30 日

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

计划入组 36 人 · 首次发布于 2025 年 3 月 5 日

Naphthalene Trisulfonate

C₁₀H₅O₉S₃

naphthalene-1,2,4,5,7-pentol

C₁₀H₈O₅

Naphthalene-2,6-disulfonic acid

C₁₀H₈O₆S₂

Qualigen Therapeutics Secures Global Patent Protection for Cancer Drug QN-302 Across 25+ Countries

Novel Nanoparticle Formulations Enhance Paclitaxel Delivery to Cancer Tumors

Machine Learning and Chemical Features Unlock Mycomembrane Permeation in Mycobacterium tuberculosis